FierceBiotech 2026-01-20 Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years
FierceBiotech 2026-01-20 Boundless finally gives up on combo treatment of 2 unimpressive cancer drugs
FierceBiotech 2026-01-20 Bristol Myers Squibb taps Microsoft's AI detection network for speedy lung cancer diagnosis
FierceBiotech 2026-01-20 Tanabe Pharma's oral drug scores in ph. 3 rare disease study, though details remain in the dark
Illumina 2026-01-20 Illumina Gets Reimbursement For FDA-Approved TruSight Oncology Comprehensive Test, Stock Down - Nasdaq
Illumina 2026-01-20 Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology - PR Newswire